Alexander Baxter Smith
8Patents
4h-index
31Co-inventors
53Inventor score
Filing activity: Nov 22, 2001 → Dec 21, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6943160B2 | Morpholine derivatives as antagonists of orexin receptors | Chemistry; Metallurgy | 10 | Expired |
| US9949979B2 | Use of inhibitors of the activity or function of PI3K | Emerging Cross-Sectional Technologies | 9 | Active |
| US9315500B2 | Bicyclic heteroaryl cycloalkyldiamine derivatives | Human Necessities | 9 | Active |
| US9763952B2 | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | Emerging Cross-Sectional Technologies | 9 | Active |
| US8653092B2 | Tetrahydro-pyrido-pyrimidine derivatives | Human Necessities | 1 | Active |
| US9539260B2 | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US9290481B2 | Monocyclic heteroaryl cycloalkyldiamine derivatives | Human Necessities | 0 | Active |
| US9499536B2 | Tetrahydro-pyrido-pyrimidine derivatives | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.